BioTuesdays
ReWalk Robotics

HCW cuts ReWalk Robotics PT to $3.50 from $9

H.C. Wainwright lowered its price target for ReWalk Robotics (NASDAQ:RWLK) to $3.50 from $9, reflecting dilution from a recent public offering. The stock closed at 81 cents on Feb. 20. As a result of the financing, the...

Endologix

BTIG halves Endologix PT to $6 from $12

BTIG halved its price target for Endologix (NASDAQ:ELGX) to $6 from $12, but maintained its “buy” rating, saying the new target better reflects the current stock price, which closed at 89 cents on Feb. 19. Endologix...

Tivity Health

WB cuts Tivity Health to market perform

William Blair downgraded Tivity Health (NASDAQ:TVTY) to “market perform” after fourth quarter results missed consensus estimates and Tivity announced the departure of several senior executives. The stock closed at $22...

Agile Therapeutics

Maxim ups Agile Therapeutics PT to $8 from $3

Maxim Group raised its price target for Agile Therapeutics (NASDAQ:AGRX) to $8 from $3 after the FDA approved the company’s weekly contraceptive patch, Twirla. The stock closed at $4.07 on Feb. 14. Agile shares...

Co-Diagnostics

Maxim ups Co-Diagnostics PT to $5 from $2

Maxim Group raised its price target for Co-Diagnostics (NASDAQ:CODX) to $5 from $2, citing the company’s rapid development of a coronavirus test. The stock closed at $3.32 on Feb. 14. Analyst Jason McCarthy writes that...

Acasti Pharma

HCW halves Acasti Pharma PT to $3 from $6

H.C. Wainwright halved its price target for Acasti Pharma (NASDAQ:ACST) to $3 from $6 in light of the continued uncertainty around the company’s TRILOGY 1 and TRILOGY 2 trials. The stock closed at 57 cents on Feb. 14...

Sensus Healthcare

AGP ups Sensus Healthcare to buy; PT $6

Alliance Global Partners upgraded Sensus Healthcare (NASDAQ:SRTS) to “buy” from “neutral” with a price target of $6 after the company reported fourth quarter results. The stock closed at $4.62 on Feb. 13. Analyst Ben...

Harvest Health & Recreation

AGP starts Harvest Health at buy; PT $8

Alliance Global Partners launched coverage of Harvest Health & Recreation (CSE:HARV) with a “buy” rating and price target of $8 (Canadian). The stock closed at $3.57 on Feb. 10. “We believe the company is well...

Curaleaf Holdings

AGP starts Curaleaf Holdings at buy; PT $14

Alliance Global Partners initiated coverage of Curaleaf Holdings (CSE:CURA) with a “buy” rating and price target of $14 (Canadian). The stock closed at $8.56 on Feb. 10. “We view Curaleaf as well-positioned to succeed...

Abeona Therapeutics

SVB Leerink starts Abeona Therapeutics at OP; PT $6

SVB Leerink initiated coverage of Abeona Therapeutics (NASDAQ:ABEO) with an “outperform” rating and $6 price target. The stock closed at $2.51 on Feb. 7. “Abeona is a clinical stage gene therapy company with a realistic...

Heat Biologics

Maxim starts Heat Biologics at buy; PT $1

Maxim Group launched coverage of Heat Biologics (NASDAQ:HTBX) with a “buy” rating and price target of $1. The stock closed at 26 cents on Feb. 5. Heat is developing lead asset, ImPACT, a cell-based immune therapy for...

Subscribe

Sign up to our weekly BioTuesdays newsletter.